Bio-link Australia Pty. Ltd.

1st October 2015 – Bio-Link scouting for Inflammation and Fibrosis Drug Candidates

Bio-Link is currently scouting for in-licensing opportunities on behalf of a biopharmaceutical company client. We are interested in drug candidates at a preclinical lead (or further advanced) stage of development, with a primary focus on inflammation or fibrosis, for the lung, liver or kidney. Bio-Link Executive Director, Dr Christian Toouli, will be attending the AusBiotech 2015 Conference (Melbourne, 7 – 9th October) and would be pleased to meet with companies and institutions which are interested to potentially license or partner relevant drug candidates with a leading biopharma company. The Murdoch Childrens Research Institute received $600K in grant funding to support further development of the FREE Fragile-X diagnostic technology for FMR1-related disorders, including Fragile X Syndrome, have a look at the management development professionals.

bio-link square-linkedin150925